Taro Pharmaceutical Industries Acquires Alchemee (Formerly The Proactiv Company) From Galderma

February 28, 2022

Taro Pharmaceutical Industries (NYSE: TARO) completed its acquisition of Alchemee, formerly The Proactiv Company (TPC), from Galderma. The deal transfers Alchemee’s worldwide business and assets, including the Proactiv brand, expanding Taro’s position in the over-the-counter dermatology space.

Buyers
Taro Pharmaceutical Industries Ltd.
Targets
Alchemee, formerly The Proactiv Company (TPC)
Sellers
Galderma
Location
United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.